Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Nicolai · SciRah

Researcher profile · Semantic Scholar

J. Nicolai

Share profile

J. Nicolai — researcher profile on SciRah

h-index: 3
Works: 7
Citations: 21

Most-cited papers

Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations
L. Westerink, J. Nicolai, C. Samuelsen, H. Smit +3 more
2020European Journal of Health Economics10 citations Open access
Semantic Scholar
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
L. Westerink, J. Nicolai, Marten Postma, J. V. van Boven +1 more
2022PharmacoEconomics - Open5 citations Open access
Semantic Scholar
The Budget Impact Of Duoresp® Spiromax® Compared With Commonly Prescribed Dry Powder Inhalers For The Management Of Asthma And Chronic Obstructive Pulmonary Disease In Italy: Estimated Impact Of Inhalation Technique.
S. Torvinen, J. Nicolai, S. Pulimeno, L. di Nola +8 more
2015Value in Health4 citations Open access
Semantic Scholar
The Potential Societal Cost Benefits Of Increasing Patient Satisfaction By Using An Inhaler With Improved Features Compared To Spiriva® Handihaler® For The Management Of Chronic Obstructive Pulmonary Disease (Copd) In The Uk.
J. Nicolai, S. Torvinen, U. Comberiati, R. Miles +3 more
2015Value in Health1 citations Open access
Semantic Scholar
The Budget Impact Of An Inhaler With Improved Features Compared To Spiriva® Handihaler® For The Management Of Chronic Obstructive Pulmonary Disease (Copd) In The Uk: Estimated Impact On Unscheduled Healthcare Costs And Inhaler Satisfaction.
J. Nicolai, S. Torvinen, D. J. Howard, R. Miles +3 more
2015Value in Health1 citations Open access
Semantic Scholar
PRS5 Cost-Effectiveness of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD) in the Netherlands
L. Westerink, J. Nicolai, M. Postma, J. V. van Boven +1 more
20200 citations Open access
Semantic Scholar
PCN187 BUDGET IMPACT OF SEQUENTIAL TREATMENT WITH AFATINIB FOLLOWED BY OSIMERTINIB VERSUS FIRST-LINE OSIMERTINIB IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH COMMON EGFR MUTATIONS IN THE NETHERLANDS
L. Westerink, J. Nicolai, C. Samuelsen, Ingolf Griebsch +1 more
2019Value in Health0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Westerink×4
Invite
L. Westerink — researcher profile on SciRah
M. Postma×3
Invite
M. Postma — researcher profile on SciRah
S. Torvinen×3
Invite
S. Torvinen — researcher profile on SciRah
A. Plich×3
Invite
A. Plich — researcher profile on SciRah

×2

Invite

C. Samuelsen — researcher profile on SciRah

Invite

C. Boersma — researcher profile on SciRah

U. Comberiati×2

Invite

U. Comberiati — researcher profile on SciRah

Invite

R. Miles — researcher profile on SciRah

Invite

M. Greaney — researcher profile on SciRah

D. J. Howard×2

Invite

D. J. Howard — researcher profile on SciRah

Invite

H. Smit — researcher profile on SciRah

Invite

P. Postmus — researcher profile on SciRah